"10.1371_journal.pone.0072645","plos one","2013-08-26T00:00:00Z","Haijun Tian; Xiaoda Bi; Chen-Shuang Li; Ke-Wei Zhao; Elsa J Brochmann; Scott R Montgomery; Bayan Aghdasi; Deyu Chen; Michael D Daubs; Jeffrey C Wang; Samuel S Murray","Department of Orthopaedic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, P. R. China; Department of Ophthalmology, the 309th Hospital of PLA, Beijing, P. R. China; Department of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, P. R. China; Research Service, Education and Clinical Center, VA Greater Los Angeles Healthcare System, North Hills, California, United States of America; Geriatric Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, North Hills, California, United States of America; Department of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Physiology, University of California Los Angeles, Los Angeles, California, United States of America; Department of Orthopaedic Surgery, University of California Los Angeles, Los Angeles, California, United States of America; Department of Orthopaedic Surgery, the Methodist Hospital System, Houston, Texas, United States of America","Conceived and designed the experiments: HT EJB MDD JCW SSM. Performed the experiments: HT XB CL KZ EJB SRM BA DC SSM. Analyzed the data: HT KZ EJB SRM MDD JCW SSM. Wrote the manuscript: HT KZ EJB SSM.","Dr. Jeffrey C. Wang or one of his immediate family own stock or stock options in the following pharmaceutical, biomaterial or orthopaedic device or equipment company, or suppliers: Fziomed, Promethean spine, Paradigm spine, Benevenue, NexGen, Pioneer, Amedica, Vertiflex, Electrocore, Surgitech, Axiomed, VG Innovations, Corespine, Expanding orthopaedics, Syndicom, Osprey, Bone biologics, Curative biosciences, Pearldiver. Dr. Jeffrey C. Wang or a member of his immediate family receive royalties for the following pharmaceutical, biomaterialor orthopaedic product or devices: Biomet, Stryker, Medtronics, Depuy-Synthes, Amedica, Osprey, Aesculap, Seaspine. Dr. Michael D. Daubs receive royalties and is a paid consultant for the orthopaedic product or device: Dupuy-Synthes. Dr. Michael D. Daubs receives research or institutional support as a principal investigator from the orthopaedic device company Stryker. The disclosed competing interests do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Haijun Tian","HT",11,TRUE,5,9,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
